Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-08 | Stengone Carmine N. | Director & CEO and President | Sale | 2,500 | $16.46 | $41K | 17.2K | View | |
| 2026-07-09 | 2026-07-10 | Lorrain Daniel S. | Chief Scientific Officer | Sale | 25 | $16.00 | $400.00 | 135.2K | View | |
| 2026-07-08 | 2026-07-10 | Lorrain Daniel S. | Chief Scientific Officer | Sale | 1,015 | $16.00 | $16K | 135.2K | View | |
| 2026-07-08 | 2026-07-08 | Stengone Carmine N. | Director & CEO and President | Sale | 2,500 | $16.00 | $40K | 17.2K | View | |
| 2026-07-01 | 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Sale | 8,353 | $15.84 | $132K | 135.2K | View |
Informational purposes only, not investment advice.
tormere.com/research/CTNM · generated 2026-10-05
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-08 | Stengone Carmine N. | S | 2,500 | $41,141.5 |
| 2026-07-09 | Lorrain Daniel S. | S | 25 | $400 |
| 2026-07-08 | Lorrain Daniel S. | S | 1,015 | $16,240 |
| 2026-07-08 | Stengone Carmine N. | S | 2,500 | $40,000 |
| 2026-07-01 | Lorrain Daniel S. | S | 5,852 | $91,681.53 |
Tormere — informational purposes only, not investment advice.